-
Ndị na-ahụ maka ọgwụ |Immunology |Ngwakọta peptide |Natural Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |CAS Nọmba: 197632-75-0
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Immunology |Ngwakọta peptide |Natural Amino Acid |Fmoc-N-Me-Trp(Boc)-OH |CAS: 197632-75-0 |C32H32N2O6
-
Ndị na-ahụ maka ọgwụ |Immunology |Ngwakọta peptide |Fmoc-Trp-OH |CAS Nọmba: 35737-15-6 |C26H22N2O4
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Immunology |Ngwakọta peptide |Natural Amino Acid |Fmoc-Trp-OH |CAS: 35737-15-6 |C26H22N2O4
-
Ndị na-ahụ maka ọgwụ |Immunology |Ngwakọta peptide |Fmoc-His(Trt) -OH |CAS Nọmba: 109425-51-6 |C40H33N3O4
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Immunology |Ngwakọta peptide |Natural Amino Acid |Fmoc-His(Trt) -OH |CAS: 109425-51-6 |C40H33N3O4
-
Ndị na-ahụ maka ọgwụ |Immunology |Ngwakọta peptide |Fmoc-Lys(Boc) -OH |CAS Nọmba: 71989-26-9
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Immunology |Ngwakọta peptide |Natural Amino Acid |Fmoc-Lys(Boc) -OH |CAS: 71989-26-9 |C26H32N2O6
-
Fmoc-D-Trp(Boc) -OH 163619-04-3
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Immunology |Ngwakọta peptide |Natural Amino Acid |Fmoc-D-Trp(Boc)-OH |CAS: 163619-04-3 |C31H30N2O6
-
Ndị na-ahụ maka ọgwụ |Ọrịa iku ume |Pranlukast Intermediates |3′-Acetylamino-2′-hydroxyacetophenone |CAS No.103205-33-0
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ndị na-ahụ maka ọgwụ etiti |Akụrụngwa |Ọrịa iku ume |Pranlukast Intermediates |3′-Acetylamino-2′-hydroxyacetophenone |CAS: 103205-33-0 |C10H11NO3
-
Ndị na-ahụ maka ọgwụ |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYCINE |CAS No.42288-26-6
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ndị na-ahụ maka ọgwụ etiti |Akụrụngwa |Anticoagulant API |Dabigatran Intermediates |N-(4-CYANO-PHENYL)-GLYCINE |CAS: 42288-26-6 |C9H8N2O2
-
Ndị na-ahụ maka ọgwụ |Integrin antagonist |Ndị etiti Lifitegrast |3-Bromo-L-phenylalanine |CAS No.82311-69-1
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ |Ndị etiti Lifitegrast |3-Bromo-L-phenylalanine |CAS: 82311-69-1 |C9H10BrNO2
-
Ndị na-ahụ maka ọgwụ |Integrin antagonist |Ndị etiti Lifitegrast |Boc-3-bromo-L-phenylalanine |CAS No.82278-73-7
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ |Integrin antagonist |Ndị etiti Lifitegrast |Boc-3-bromo-L-phenylalanine |CAS: 82278-73-7 |C14H18BrNO4
-
Ngwa akụrụngwa akụrụngwa na etiti |Ọrịa shuga |(R) -3-Aminopperidine dihydrochloride |CAS No.334618-23-4
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ngwakọta ọgwụ na-arụ ọrụ |Ọrịa shuga |(R) -3-Aminopperidine dihydrochloride |CAS: 334618-23-4 |C5H14Cl2N2
-
Ndị na-ahụ maka ọgwụ |(R) -1-Boc-3-Aminoperidine |Ọrịa shuga |CAS: 188111-79-7
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Ndị na-ahụ maka ọgwụ |(R) -1-Boc-3-Aminoperidine |CAS: 188111-79-7 |C10H20N2O2
-
Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ |Ọrịa obi |Ọrịa |(S)-(-)-Indoline-2-carboxylic acid |CAS No.79815-20-6
Ndị ọkachamara n'ichepụta na inye biopharmaceutical |Ngwa akụrụngwa |Ndị na-ahụ maka ọgwụ etiti |Ọrịa obi |Ọbara Ọbara |(S)-(-)-Indoline-2-carboxylic acid |CAS: 79815-20-6 |C9H9NO2